| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |